Title | Type | SJR | H index | Total Docs. (2005) | Total Docs. (3years) | Total Refs. (2005) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2005) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.464 Q1 | 82 | 11 | 40 | 2379 | 229 | 40 | 4.88 | 216.27 | |
2 | Reviews of Physiology Biochemistry and Pharmacology | journal | 5.545 Q1 | 70 | 10 | 40 | 2129 | 395 | 40 | 10.18 | 212.90 | |
3 | Drug Metabolism Reviews | journal | 1.191 Q1 | 108 | 21 | 101 | 4103 | 459 | 99 | 4.10 | 195.38 | |
4 | Pharmacological Reviews | journal | 9.872 Q1 | 254 | 30 | 73 | 5479 | 1707 | 71 | 16.30 | 182.63 | |
5 | Pharmacology and Therapeutics | journal | 3.888 Q1 | 233 | 85 | 183 | 14160 | 1752 | 180 | 9.45 | 166.59 | |
6 | Natural Product Reports | journal | 3.169 Q1 | 211 | 39 | 132 | 6176 | 988 | 128 | 6.70 | 158.36 | |
7 | Infectious Disorders - Drug Targets | journal | 0.992 Q1 | 61 | 31 | 94 | 4786 | 277 | 87 | 2.64 | 154.39 | |
8 | Current Neuropharmacology | journal | 0.505 Q3 | 103 | 23 | 32 | 3390 | 42 | 30 | 1.31 | 147.39 | |
9 | CNS and Neurological Disorders - Drug Targets | journal | 2.095 Q1 | 96 | 63 | 126 | 9179 | 723 | 123 | 5.00 | 145.70 | |
10 | Annual Review of Pharmacology and Toxicology | journal | 10.789 Q1 | 224 | 29 | 71 | 4036 | 1677 | 71 | 22.75 | 139.17 | |
11 | Current Medicinal Chemistry | journal | 1.709 Q1 | 202 | 184 | 560 | 24924 | 2846 | 526 | 5.20 | 135.46 | |
12 | Current Cancer Drug Targets | journal | 2.351 Q1 | 103 | 49 | 112 | 6470 | 650 | 109 | 5.93 | 132.04 | |
13 | Medicinal Research Reviews | journal | 2.935 Q1 | 150 | 29 | 80 | 3798 | 789 | 80 | 9.22 | 130.97 | |
14 | Studies in Natural Products Chemistry | book series | 0.419 Q3 | 49 | 50 | 83 | 6400 | 71 | 45 | 1.05 | 128.00 | |
15 | Current Pharmaceutical Design | journal | 1.647 Q1 | 183 | 314 | 799 | 38219 | 3835 | 697 | 4.89 | 121.72 | |
16 | Expert Opinion on Therapeutic Targets | journal | 0.999 Q1 | 106 | 89 | 169 | 10586 | 417 | 159 | 2.62 | 118.94 | |
17 | Expert Opinion on Emerging Drugs | journal | 0.570 Q2 | 54 | 53 | 88 | 6214 | 194 | 86 | 2.83 | 117.25 | |
18 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.425 Q1 | 108 | 47 | 129 | 5410 | 529 | 122 | 3.39 | 115.11 | |
19 | Current Drug Metabolism | journal | 1.926 Q1 | 122 | 42 | 120 | 4777 | 773 | 114 | 6.16 | 113.74 | |
20 | Handbook of Experimental Pharmacology | journal | 0.122 Q4 | 110 | 152 | 1 | 17170 | 0 | 1 | 0.00 | 112.96 | |
21 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.009 Q1 | 99 | 12 | 40 | 1342 | 143 | 39 | 3.47 | 111.83 | |
22 | Drug Design Reviews Online | journal | 11 | 48 | 0 | 5344 | 0 | 0 | 0.00 | 111.33 | ||
23 | Current Pharmacogenomics | journal | 0.224 Q3 | 12 | 24 | 32 | 2670 | 25 | 32 | 0.78 | 111.25 | |
24 | Medicinal Chemistry Reviews - Online | journal | 7 | 46 | 0 | 5102 | 0 | 0 | 0.00 | 110.91 | ||
25 | Critical Reviews in Toxicology | journal | 1.850 Q1 | 129 | 36 | 49 | 3985 | 298 | 47 | 5.45 | 110.69 | |
26 | Anti-Infective Agents | journal | 0.322 Q3 | 26 | 23 | 24 | 2527 | 27 | 22 | 1.13 | 109.87 | |
27 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.611 Q2 | 43 | 38 | 53 | 4157 | 119 | 53 | 2.25 | 109.39 | |
28 | Progress in Medicinal Chemistry | journal | 1.045 Q1 | 38 | 8 | 26 | 868 | 80 | 22 | 2.67 | 108.50 | |
29 | Current Drug Targets | journal | 1.451 Q1 | 119 | 92 | 172 | 9901 | 730 | 160 | 4.40 | 107.62 | |
30 | Drug Resistance Updates | journal | 2.708 Q1 | 132 | 29 | 87 | 3075 | 606 | 82 | 6.79 | 106.03 | |
31 | Current Drug Targets: Inflammation and Allergy | journal | 1.265 Q1 | 53 | 88 | 110 | 9313 | 358 | 106 | 2.74 | 105.83 | |
32 | Current Gene Therapy | journal | 1.077 Q1 | 80 | 58 | 114 | 6023 | 467 | 112 | 3.65 | 103.84 | |
33 | Progress in Drug Research | book series | 1.063 Q1 | 46 | 23 | 39 | 2369 | 125 | 35 | 2.80 | 103.00 | |
34 | Neurotherapeutics | journal | 0.712 Q2 | 136 | 58 | 51 | 5904 | 131 | 45 | 2.57 | 101.79 | |
35 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 5 | 16 | 506 | 0 | 16 | 0.00 | 101.20 | ||
36 | Expert Opinion on Drug Metabolism and Toxicology | journal | 100 | 51 | 0 | 5082 | 0 | 0 | 0.00 | 99.65 | ||
37 | Current Vascular Pharmacology | journal | 0.869 Q2 | 69 | 42 | 70 | 4147 | 156 | 70 | 2.23 | 98.74 | |
38 | American Journal of Drug Delivery | journal | 0.344 Q3 | 23 | 21 | 20 | 2033 | 16 | 20 | 0.80 | 96.81 | |
39 | Current Medicinal Chemistry: Immunology, Endocrine and Metabolic Agents | journal | 11 | 64 | 36 | 5982 | 12 | 32 | 0.33 | 93.47 | ||
40 | Neurotoxicity Research | journal | 0.772 Q2 | 84 | 52 | 181 | 4834 | 390 | 177 | 2.13 | 92.96 | |
41 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.678 Q2 | 45 | 52 | 71 | 4786 | 125 | 65 | 1.90 | 92.04 | |
42 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.135 Q4 | 27 | 70 | 31 | 6427 | 13 | 28 | 0.42 | 91.81 | |
43 | Mini-Reviews in Medicinal Chemistry | journal | 0.828 Q2 | 107 | 99 | 224 | 8937 | 621 | 215 | 2.78 | 90.27 | |
44 | Advanced Drug Delivery Reviews | journal | 2.713 Q1 | 366 | 145 | 336 | 13073 | 3197 | 286 | 7.73 | 90.16 | |
45 | Cellular and Molecular Life Sciences | journal | 2.691 Q1 | 261 | 271 | 707 | 24423 | 3766 | 702 | 4.94 | 90.12 | |
46 | BioDrugs | journal | 0.649 Q2 | 79 | 35 | 137 | 3137 | 357 | 133 | 2.30 | 89.63 | |
47 | Expert Opinion on Drug Delivery | journal | 0.372 Q2 | 133 | 81 | 16 | 7108 | 25 | 14 | 1.56 | 87.75 | |
48 | Expert Opinion on Biological Therapy | journal | 0.943 Q1 | 102 | 140 | 378 | 11936 | 1061 | 365 | 2.90 | 85.26 | |
49 | Expert Opinion on Investigational Drugs | journal | 1.059 Q1 | 117 | 137 | 423 | 11445 | 1588 | 412 | 3.61 | 83.54 | |
50 | Current Topics in Medicinal Chemistry | journal | 1.796 Q1 | 133 | 132 | 319 | 10394 | 1678 | 297 | 4.60 | 78.74 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®